Potential vulnerability markers within the affective domain in subjects at genetic and clinical high risk for schizophrenia

Psychopathology

Volumn 41, Issue 4, 2008, Pages 236-244

  Lee, Seung Jae ^a   Yoo, So Young ^a   Kang, Do Hyung ^a   Lee, Kyung Jin ^a   Ha, Tae Hyun ^a   Wee, Whee ^b   Lee, Ae Ra ^a   Kim, Nam Sick ^a   Kwon, Jun Soo ^a  

^a Seoul National University   (South Korea)

^b Andong Science College   (South Korea)

Author keywords

Affective functioning; High risk; Schizophrenia; Vulnerability marker

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGGRESSION; ARTICLE; CONTROLLED STUDY; EMOTIONAL DISORDER; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; MOOD DISORDER; PSYCHOLOGIC ASSESSMENT; RISK ASSESSMENT; SCHIZOPHRENIA; VULNERABLE POPULATION;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; ADULT; AFFECT; AFFECTIVE SYMPTOMS; AWARENESS; CHRONIC DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 43649099839     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000125557     Document Type: Article

References (64)

1. Murray RM, Lewis SW: Is schizophrenia a neurodevelopmental disorder? Br Med J (Clin Res Ed) 1988;296:63.
2. Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-669.
3. Bearden CE, Rosso IM, Hollister JM, Sanchez LE, Hadley T, Cannon TD: A prospective cohort study of childhood behavioral deviance and language abnormalities as predictors of adult schizophrenia. Schizophr Bull 2000;26:395-410.
4. Cannon TD, Rosso IM, Hollister JM, Bearden CE, Sanchez LE, Hadley T: A prospective cohort study of genetic and perinatal influences in the etiology of schizophrenia. Schizophr Bull 2000;26:351-366.
5. Woods BT: Is schizophrenia a progressive neurodevelopmental disorder? Toward a unitary pathogenetic mechanism. Am J Psychiatry 1998;155:1661-1670.
6. Cannon TD, van Erp TG, Bearden CE, Loewy R, Thompson P, Toga AW, Huttunen MO, Keshavan MS, Seidman LJ, Tsuang MT: Early and late neurodevelopmental influences in the prodrome to schizophrenia: contributions of genes, environment, and their interactions. Schizophr Bull 2003;29:653-669.
7. Cannon TD: Clinical and genetic high-risk strategies in understanding vulnerability to psychosis. Schizophr Res 2005;79:35-44.
8. Owens DG, Johnstone EC: Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context. Psychol Med 2006;36:1501-1514.
9. Miller TJ, McGlashan TH, Woods SW, Stein K, Driesen N, Corcoran CM, Hoffman R, Davidson L: Symptom assessment in schizophrenic prodromal states. Psychiatr Q 1999;70:273-287.
10. Yung AR, McGorry PD, Jackson HJ, Patton GC, Rakkar A: Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull 1996;22:283-303.
11. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E: The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull 2003;29:633-651.
12. Brewer WJ, Wood SJ, Phillips LJ, Francey SM, Pantelis C, Yung AR, Cornblatt B, McGorry PD: Generalized and specific cognitive performance in clinical high-risk cohorts: a review highlighting potential vulnerability markers for psychosis. Schizophr Bull 2006;32:538-555.
13. Keshavan MS, Diwadkar VA, Montrose DM, Rajarethinam R, Sweeney JA: Premorbid indicators and risk for schizophrenia: a selective review and update. Schizophr Res 2005;79:45-57.
14. Olsen KA, Rosenbaum B: Prospective investigations of the prodromal state of schizophrenia: review of studies. Acta Psychiatr Scand 2006;113:247-272.
15. Brewer WJ, Francey SM, Wood SJ, Jackson HJ, Pantelis C, Phillips LJ, Yung AR, Anderson VA, McGorry PD: Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 2005;162:71-78.
16. Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L, Cornblatt BA: Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 2006;59:863-871.
17. Johnstone EC, Ebmeier KP, Miller P, Owens DG, Lawrie SM: Predicting schizophrenia: findings from the Edinburgh High-Risk Study. Br J Psychiatry 2005;186:18-25.
18. Whyte MC, Brett C, Harrison LK, Byrne M, Miller P, Lawrie SM, Johnstone EC: Neuropsychological performance over time in people at high risk of developing schizophrenia and controls. Biol Psychiatry 2006;59:730-739.
19. Martin RL, Cloninger CR, Guze SB, Clayton PJ: Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry 1985;46:9-13.
20. Sands JR, Harrow M: Depression during the longitudinal course of schizophrenia. Schizophr Bull 1999;25:157-171.
21. Hafner H, Loffler W, Maurer K, Hambrecht M, an der Heiden W: Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999;100:105-118.
22. Yung AR, McGorry PD: The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 1996;22:353-370.
23. An der Heiden W, Hafner H: The epidemiology of onset and course of schizophrenia. Eur Arch Psychiatry Clin Neurosci 2000;250:292-303.
24. Drake RJ, Pickles A, Bentall RP, Kinderman P, Haddock G, Tarrier N, Lewis SW: The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med 2004;34:285-292.
25. Garety PA, Kuipers E, Fowler D, Freeman D, Bebbington PE: A cognitive model of the positive symptoms of psychosis. Psychol Med 2001;31:189-195.
26. Iqbal Z, Birchwood M, Chadwick P, Trower P: Cognitive approach to depression and suicidal thinking in psychosis. 2. Testing the validity of a social ranking model. Br J Psychiatry 2000;177:522-528.
27. Krabbendam L, Myin-Germeys I, Hanssen M, de Graaf R, Vollebergh W, Bak M, van Os J: Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br J Clin Psychol 2005;44:113-125.
28. Dworkin RH, Cornblatt BA, Friedmann R, Kaplansky LM, Lewis JA, Rinaldi A, Shilliday C, Erlenmeyer-Kimling L: Childhood precursors of affective vs. social deficits in adolescents at risk for schizophrenia. Schizophr Bull 1993;19:563-577.
29. Owens DG, Miller P, Lawrie SM, Johnstone EC: Pathogenesis of schizophrenia: a psychopathological perspective. Br J Psychiatry 2005;186:386-393.
30. Yung AR, Phillips LJ, McGorry PD, Ward J, Donovan K, Tompson K: Comprehensive Assessment of At Risk Mental States (CAARMS). Melbourne, PACE Clinic, University of Melbourne, Department of Psychiatry, 2002.
31. Hodges A, Byrne M, Grant E, Johnstone E: People at risk of schizophrenia: sample characteristics of the first 100 cases in the Edinburgh High-Risk Study. Br J Psychiatry 1999;174:547-553.
32. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, American Psychiatric Association, 1994.
33. Maxwell ME: Manual for the FIGS (unpublished manuscript). Bethesda, Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health, 1992.
34. First ME, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSMIV Axis I Disorders. New York, New York State Psychiatric Institute, 1999.
35. Kay SR, Fiszbein A, Opler LA: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
36. Overall JE, Gorham DR: The brief psychiatric rating scale. Psychol Rep 1962;10:799-812.
37. Andreasen NC: The Scale of the Assessment of Negative Symptoms. Iowa City, University of Iowa, 1983.
38. Andreasen NC: The Scale of the Assessment of Positive Symptoms. Iowa City, University of Iowa, 1984.
39. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-435.
40. Hamilton M: Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
41. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-55.
42. Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-1111.
43. Salovey P, Mayer JD, Goldman S, Turvey C, Palfai T: Emotional attention, clarity and repair: exploring emotional intelligence using the Train Meta-Mood Scale;in Pennebaker JW (ed): Emotion, Disclosure, and Health. Washington, American Psychological Association, 1995, pp 125-154.
44. Lee SJ, Lee HK: The Research on the validation of the Trait Meta-Mood Scale: the domain exploration of the emotional intelligence. Korean J Soc Pers Psychol 1997;11:95-116.
45. Roh D, Lee J: A study of the validation of the EPS. Korean J Pers Individ Dif 1998;7:72-79.
46. Eysenck HJ, Eysenck SBG: The Eysenck Personality Questionnaire. London, Hodder & Stoughton, 1975.
47. Kring AM, Smith DA, Neale JM: Individual differences in dispositional expressiveness: development and validation of the emotional expressivity scale. J Pers Soc Psychol 1994;66:934-949.
48. Roger D, Najarian B: The construction and validation of a new scale for measuring emotional control. Pers Individ Dif 1989;10:845-853.
49. Yoon S: Influences of the Affect Infusion and Affect Control Variables' Judgement and Problem Solving (doctoral thesis). Seoul, Korea University, 2002.
50. Watson D, Clark LA, Tellegen A: Development and validation of brief measure of positive and negative affect: the PANAS scales. J Pers Soc Psychol 1988;54:1063-1070.
51. Lee HH, Kim EJ, Lee MH: A validation study of Korea Positive and Negative Affect Schedule: the PANAS Scales. Korean J Clin Psychol 2003;22:935-946.
52. Rogers JL, Howard KI, Vessey JT: Using significance tests to evaluate equivalence between two experimental groups. Psychol Bull 1993;113:553-565.
53. Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175-191.
54. Miller RG: Simultaneous Statistical Inference. New York, Springer, 1986.
55. Aleman A, Kahn RS: Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 2005;77:283-298.
56. Mandal MK, Pandey R, Prasad AB: Facial expressions of emotions and schizophrenia: a review. Schizophr Bull 1998;24:399-412.
57. Tremeau F: A review of emotion deficits in schizophrenia. Dialogues Clin Neurosci 2006;8:59-70.
58. Cedro A, Kokoszka A, Popiel A, Narkiewicz-Jodko W: Alexithymia in schizophrenia: an exploratory study. Psychol Rep 2001;89:95-98.
59. Kerns JG: Positive schizotypy and emotion processing. J Abnorm Psychol 2005;114:392-401.
60. Shaw WS, Patterson TL, Semple SJ, Dimsdale JE, Ziegler MG: Emotional expressiveness, hostility and blood pressure in a longitudinal cohort of Alzheimer caregivers. J Psychosom Res 2003;54:293-302.
61. Blanchard JJ, Mueser KT, Bellack AS: Anhedonia, positive and negative affect, and social functioning in schizophrenia. Schizophr Bull 1998;24:413-424.
62. Kwapil TR: Social anhedonia as a predictor of the development of schizophrenia-spectrum disorders. J Abnorm Psychol 1998;107:558-565.
63. Erlenmeyer-Kimling L, Cornblatt BA, Rock D, Roberts S, Bell M, West A: The New York High-Risk Project: anhedonia, attentional deviance, and psychopathology. Schizophr Bull 1993;19:141-153.
64. Freedman LR, Rock D, Roberts SA, Cornblatt BA, Erlenmeyer-Kimling L: The New York High-Risk Project: attention, anhedonia and social outcome. Schizophr Res 1998;30:1-9.